Go Pro

Orthofix Medical (OFIX) Competitors

Orthofix Medical logo
$9.64 -0.15 (-1.53%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$9.90 +0.26 (+2.69%)
As of 08/25/2026 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OFIX vs. MMSI, INSP, TNDM, KMTS, and OMCL

Should you buy Orthofix Medical stock or one of its competitors? Orthofix Medical's main competitors and comparable companies include Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), and Omnicell (OMCL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Orthofix Medical compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Orthofix Medical (NASDAQ:OFIX) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Merit Medical Systems has a net margin of 9.22% compared to Orthofix Medical's net margin of -7.41%. Merit Medical Systems' return on equity of 13.75% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
Orthofix Medical -7.41%-14.05%-7.17%

Merit Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B3.59$128.49M$2.4237.64
Orthofix Medical$822.31M0.48-$92.19M-$1.54N/A

Merit Medical Systems presently has a consensus target price of $100.00, indicating a potential upside of 9.78%. Orthofix Medical has a consensus target price of $14.75, indicating a potential upside of 53.01%. Given Orthofix Medical's higher possible upside, analysts clearly believe Orthofix Medical is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Merit Medical Systems had 14 more articles in the media than Orthofix Medical. MarketBeat recorded 22 mentions for Merit Medical Systems and 8 mentions for Orthofix Medical. Merit Medical Systems' average media sentiment score of 1.10 beat Orthofix Medical's score of 1.06 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
9 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.49, indicating that its share price is 51% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by insiders. Comparatively, 2.7% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Merit Medical Systems beats Orthofix Medical on 13 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Inspire Medical Systems?

Inspire Medical Systems (NYSE:INSP) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Inspire Medical Systems has a net margin of 15.03% compared to Orthofix Medical's net margin of -7.41%. Inspire Medical Systems' return on equity of 8.64% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Orthofix Medical -7.41%-14.05%-7.17%

Inspire Medical Systems has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

In the previous week, Orthofix Medical had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 8 mentions for Orthofix Medical and 5 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.44 beat Orthofix Medical's score of 1.06 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Inspire Medical Systems has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.94$145.42M$4.6213.25
Orthofix Medical$822.31M0.48-$92.19M-$1.54N/A

Inspire Medical Systems currently has a consensus target price of $66.19, suggesting a potential upside of 8.09%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 53.01%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Orthofix Medical is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Inspire Medical Systems beats Orthofix Medical on 12 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Tandem Diabetes Care?

Orthofix Medical (NASDAQ:OFIX) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Orthofix Medical has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Orthofix Medical$822.31M0.48-$92.19M-$1.54N/A
Tandem Diabetes Care$1.01B1.48-$204.71M-$0.93N/A

Orthofix Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Tandem Diabetes Care has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market.

Tandem Diabetes Care has a net margin of -6.08% compared to Orthofix Medical's net margin of -7.41%. Orthofix Medical's return on equity of -14.05% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Orthofix Medical-7.41% -14.05% -7.17%
Tandem Diabetes Care -6.08%-45.97%-6.23%

Orthofix Medical presently has a consensus target price of $14.75, indicating a potential upside of 53.01%. Tandem Diabetes Care has a consensus target price of $28.98, indicating a potential upside of 34.27%. Given Orthofix Medical's higher possible upside, equities analysts plainly believe Orthofix Medical is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Tandem Diabetes Care
1 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.48

In the previous week, Orthofix Medical had 3 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 8 mentions for Orthofix Medical and 5 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.49 beat Orthofix Medical's score of 1.06 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tandem Diabetes Care
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.8% of Orthofix Medical shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 2.1% of Tandem Diabetes Care shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Tandem Diabetes Care beats Orthofix Medical on 10 of the 17 factors compared between the two stocks.

How does Orthofix Medical compare to Kestra Medical Technologies?

Kestra Medical Technologies (NASDAQ:KMTS) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

Orthofix Medical has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical Technologies$95.13M16.58-$131.61M-$2.42N/A
Orthofix Medical$822.31M0.48-$92.19M-$1.54N/A

Orthofix Medical has a net margin of -7.41% compared to Kestra Medical Technologies' net margin of -138.35%. Orthofix Medical's return on equity of -14.05% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical Technologies-138.35% -57.38% -41.10%
Orthofix Medical -7.41%-14.05%-7.17%

In the previous week, Orthofix Medical had 6 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 8 mentions for Orthofix Medical and 2 mentions for Kestra Medical Technologies. Orthofix Medical's average media sentiment score of 1.06 beat Kestra Medical Technologies' score of 0.58 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kestra Medical Technologies has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

89.8% of Orthofix Medical shares are owned by institutional investors. 5.3% of Kestra Medical Technologies shares are owned by insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Kestra Medical Technologies currently has a consensus price target of $28.14, indicating a potential upside of 4.54%. Orthofix Medical has a consensus price target of $14.75, indicating a potential upside of 53.01%. Given Orthofix Medical's higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Kestra Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Orthofix Medical beats Kestra Medical Technologies on 12 of the 16 factors compared between the two stocks.

How does Orthofix Medical compare to Omnicell?

Omnicell (NASDAQ:OMCL) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

Omnicell presently has a consensus price target of $57.86, suggesting a potential upside of 74.16%. Orthofix Medical has a consensus price target of $14.75, suggesting a potential upside of 53.01%. Given Omnicell's stronger consensus rating and higher possible upside, analysts clearly believe Omnicell is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omnicell
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Orthofix Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Omnicell has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market. Comparatively, Orthofix Medical has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

Omnicell has a net margin of 3.13% compared to Orthofix Medical's net margin of -7.41%. Omnicell's return on equity of 5.66% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Omnicell3.13% 5.66% 3.57%
Orthofix Medical -7.41%-14.05%-7.17%

In the previous week, Omnicell had 13 more articles in the media than Orthofix Medical. MarketBeat recorded 21 mentions for Omnicell and 8 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 1.06 beat Omnicell's score of 0.40 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omnicell
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Orthofix Medical
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Omnicell has higher revenue and earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omnicell$1.18B1.28$2.05M$0.8439.55
Orthofix Medical$822.31M0.48-$92.19M-$1.54N/A

97.7% of Omnicell shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 2.9% of Omnicell shares are held by insiders. Comparatively, 2.7% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Omnicell beats Orthofix Medical on 15 of the 16 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OFIX vs. The Competition

MetricOrthofix MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$398.77M$5.95B$7.35B$12.72B
Dividend YieldN/A1.74%2.53%11.02%
P/E Ratio-6.2626.05270.9624.14
Price / Sales0.4870.19634.76101.59
Price / CashN/A33.2778.5753.12
Price / Book0.916.2713.146.25
Net Income-$92.19M$149.30M$3.46B$347.86M
7 Day Performance-8.02%0.27%1.52%0.98%
1 Month Performance-14.31%9.20%8.82%5.24%
1 Year Performance-33.56%6.86%26.08%17.04%

Orthofix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFIX
Orthofix Medical
3.3714 of 5 stars
$9.64
-1.5%
$14.75
+53.0%
-33.5%$398.77M$822.31MN/A1,605
MMSI
Merit Medical Systems
3.7963 of 5 stars
$89.26
-0.5%
$100.00
+12.0%
+3.3%$5.33B$1.52B36.887,500
INSP
Inspire Medical Systems
3.3135 of 5 stars
$57.43
+0.4%
$66.19
+15.3%
-34.3%$1.66B$898.74M12.431,333
TNDM
Tandem Diabetes Care
3.5839 of 5 stars
$23.73
+6.7%
$28.98
+22.1%
+78.2%$1.65B$1.01BN/A2,500
KMTS
Kestra Medical Technologies
1.6571 of 5 stars
$27.93
+0.4%
$28.14
+0.8%
+51.9%$1.64B$95.13MN/A300

Related Companies and Tools


This page (NASDAQ:OFIX) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners